4//SEC Filing
Flagship Ventures Fund IV General Partner LLC 4
Accession 0000899243-20-013020
CIK 0001682852other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:12 PM ET
Size
18.8 KB
Accession
0000899243-20-013020
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Transactions
- Other
Common Stock
2020-05-11−8,390,000→ 22,826,399 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−2,281,179→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−1,610,000→ 6,580,766 total(indirect: See Footnote)
Holdings
- 3,924(indirect: See Footnote)
Common Stock
- 1,389,827(indirect: See Footnote)
Common Stock
- 11,460,435(indirect: See Footnote)
Common Stock
Flagship Ventures Fund IV-Rx, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-05-11−8,390,000→ 22,826,399 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−2,281,179→ 0 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−1,610,000→ 6,580,766 total(indirect: See Footnote)
Holdings
- 1,389,827(indirect: See Footnote)
Common Stock
- 11,460,435(indirect: See Footnote)
Common Stock
- 3,924(indirect: See Footnote)
Common Stock
Flagship Ventures Fund IV, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-05-11−1,610,000→ 6,580,766 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−8,390,000→ 22,826,399 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−2,281,179→ 0 total(indirect: See Footnote)
Holdings
- 3,924(indirect: See Footnote)
Common Stock
- 11,460,435(indirect: See Footnote)
Common Stock
- 1,389,827(indirect: See Footnote)
Common Stock
AFEYAN NOUBAR
Director
Transactions
- Other
Common Stock
2020-05-11−8,390,000→ 22,826,399 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−1,610,000→ 6,580,766 total(indirect: See Footnote) - Other
Common Stock
2020-05-11−2,281,179→ 0 total(indirect: See Footnote)
Holdings
- 11,460,435(indirect: See Footnote)
Common Stock
- 3,924(indirect: See Footnote)
Common Stock
- 1,389,827(indirect: See Footnote)
Common Stock
Footnotes (7)
- [F1]On May 11, 2020, Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") and Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx") distributed to its limited partners and sole general partner, Flagship Ventures Fund IV General Partner, LLC ("Flagship Fund IV GP"), pro rata and without consideration, 8,390,000 shares and 1,610,000 shares, respectively, of the Issuer's common stock. Flagship Fund IV GP, in turn, distributed to its members, pro rata and without consideration, the 1,959,136 shares and 322,043 shares it received from Flagship Fund IV and Flagship Fund IV-Rx, respectively. Noubar B. Afeyan, Ph.D., sole manager of Flagship Fund IV GP, received 790,980 shares through Flagship Fund IV GP's distribution. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F2]Shares held by Flagship Fund IV. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein. Edwin M. Kania, Jr. is retired both from Flagship Pioneering, Inc. ("Pioneering") and as a manager of Flagship Fund IV GP.
- [F3]Shares held by Flagship Fund IV-Rx. Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F4]Shares held by Flagship Fund IV GP. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV GP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F5]Shares held by Flagship VentureLabs IV LLC ("VentureLabs IV"). Flagship Fund IV is a member of VentureLabs IV and also serves as its manager. Flagship Fund IV GP is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F6]Shares held by Pioneering. Noubar B. Afeyan, Ph.D. is the CEO and sole stockholder of Pioneering. Each of the reporting persons except for Pioneering disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
- [F7]Shares held by Noubar B. Afeyan, Ph.D. Each of the reporting persons except for Noubar B. Afeyan, Ph.D. disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001508051
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:12 PM ET
- Size
- 18.8 KB